查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1929696

全球醫藥物流倉儲市場（按溫度控制、服務類型、儲存類型、所有權類型和最終用途分類）預測（2026-2032年）

Warehousing in Pharmaceutical Logistics Market by Temperature Control, Service Type, Storage Type, Ownership Type, End Use - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 192 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，醫藥物流倉儲市場規模將達到 90.2 億美元，到 2026 年將成長至 96.9 億美元，到 2032 年將達到 142.1 億美元，複合年成長率為 6.70%。

主要市場統計數據
基準年 2025 90.2億美元
預計年份：2026年 96.9億美元
預測年份：2032年 142.1億美元
複合年成長率 (%) 6.70%

建構藥品倉儲的策略架構：低溫運輸完整性、法規遵循性和網路韌性如何融合，從而形成競爭優勢

醫藥物流領域越來越依賴倉儲營運的完整性來維持產品品質、滿足監管要求並支持敏捷的供應鏈。治療方法複雜性的增加、低溫運輸需求的擴大以及監管審查的加強，都已使倉儲從單純的成本中心躍升為一項戰略能力。本執行摘要指出，倉儲不僅是一個儲存場所，更是一個影響病人用藥、品牌信任和商業性彈性的關鍵樞紐。

技術應用、不斷演變的外包模式以及永續性要求如何重塑藥品倉儲營運和策略重點？

技術、法規和商業模式的變革正在重新定義藥品倉儲營運的要求。先進的數位化工具，例如持續環境監測、邊緣分析和整合倉庫管理系統，已從檢查應用轉變為營運的必要組成部分。因此，許多營運商正從人工、間歇性的監控轉向持續的、數據驅動的管理，從而降低風險並實現流程標準化。這種技術轉變也提高了可追溯性和審核，而這正是監管機構和商業夥伴日益成長的需求。

探討近期美國關稅調整對營運的影響，以及這些調整對倉庫規模、庫存策略和供應鏈連續性的影響。

美國2025年前的關稅趨勢將增加藥品供應鏈決策的複雜性，影響採購、運輸管道和倉儲策略。雖然成品藥​​和許多活性藥物成分受益於優惠待遇和統一的監管通訊協定，但輔助設備、包裝材料和某些特殊組件則面臨關稅波動風險。這種波動迫使企業重新評估其在國內和國際分銷點的庫存結構。

多維度的細分框架從溫度控制、服務、儲存、最終用途和所有權等方面識別倉庫功能，並將其與產品和商業風險相匹配。

這種細分方法為將倉儲能力與產品風險狀況和商業性需求相匹配提供了切實可行的觀點。根據溫度控制方式，市場可分為常溫儲存和溫控儲存。溫控儲存可進一步細分為冷藏保管儲存和冷凍儲存。這種基於溫度的框架闡明了常溫配送和專業低溫運輸營運在資本和合規方面的差異，並突顯了不同細分市場在設施基礎設施、能源管理和驗證通訊協定方面存在顯著差異的原因。

成熟市場和新興市場的區域倉儲趨勢和分銷重點正在影響設施設計合規策略和分銷網路。

區域趨勢正對全球主要市場的倉儲需求和策略重點產生重大影響。在美洲，需求中心和監管預期正推動對地理位置分散的溫控節點和強大的低溫運輸走廊的投資，以支持快速補貨和高透明度。該地區對病患就醫便利性和商業性上市速度的重視，使得靠近病患的配送管道和可靠的第三方夥伴關係尤為重要。

重新定義醫藥倉儲物流領域的競爭優勢：供應商能力、整合服務組合和數位化透明度的作用

倉儲服務供應商之間的競爭優勢日益凸顯，其差異化體現在能力深度、合規性和與各類供應鏈服務的整合能力等方面。主要企業強調檢驗的低溫運輸基礎設施、完善的品管系統以及端到端的文件記錄能力，以支援監管機構的檢查和審核。此外，這些能力通常還會透過投資數位化平台來增強，從而實現即時溫度監控、自動偏差預警以及與客戶核心系統的無縫資料整合。

物流和供應鏈高管可以採取哪些切實可行的步驟來增強低溫運輸完整性、合約柔軟性以及永續、有韌性的倉儲營運？

行業領導者應優先考慮能夠同時降低營運風險並加快新治療方法上市速度的投資。首先，透過實施整合警報和自動化糾正工作流程的持續環境監測來加強數位化控制，從而減少人為因素對偏差的反應延遲。這有助於提高合規性，並減輕測試和不利事件調查期間的營運負擔。其次，將外包策略與臨床和商業生命週期相匹配，利用專用設施生產高價值或敏感產品，並採用靈活的合約或公共選項來管理低風險庫存。這種組合能夠在保持服務水準的同時提高資本效率。

為了檢驗我們對倉庫管理的見解，我們採用了一種透明的混合方法研究途徑，結合了專家訪談、設施觀察、細分映射和情境分析。

本研究採用多種方法，確保整體性和檢驗。主要定性資料透過對製造商、經銷商和倉儲服務商的高級供應鏈、品質和監管負責人進行結構化訪談收集。驗證和監控實踐則透過對溫控設施的現場考察進行觀察。這些直接觀察結果與二手資料進行了交叉比對，包括監管指南、行業白皮書以及關於低溫運輸物流和溫控產品管理的最新學術文獻。

最終綜合分析強調，倉儲是生命科學領域一項策略能力，它將產品完整性、監管準備和商業性回應能力連結起來。

對於檢驗公司而言，穩健的倉儲策略是決定供應鏈韌性和商業性彈性的關鍵因素。溫度控制要求、服務模式、儲存配置和所有權選擇相互作用，構成了一個複雜的決策空間，需要明確的優先事項和嚴謹的營運。投資於經過驗證的低溫運輸基礎設施、數位監控系統以及與實力雄厚的供應商夥伴關係的企業，更有可能降低產品風險，並提高其應對監管審查的能力。

目錄

第1章：序言

第2章調查方法

  • 研究設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查前提
  • 調查限制

第3章執行摘要

  • 首席體驗長觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 市場進入策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會地圖
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章 美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

8. 依溫度控制分類的醫藥物流倉儲市場

  • 室溫保存
  • 溫控存儲
    • 冷藏保管
    • 冷凍儲存

9. 依服務類型分類的醫藥物流倉儲市場

  • 合約倉庫存儲
    • 第三方物流
      • 3PL
      • 4PL
    • 附加價值服務
  • 專用倉庫
  • 公共倉庫

第10章：按儲存類型分類的醫藥物流倉儲市場

  • 散裝存儲
  • 托盤式存儲
  • 貨架存儲

第11章 依所有權類型分類的醫藥物流倉儲市場

  • 出租房產
    • 長期租賃協議
    • 短期租賃協議
  • 自有財產
    • 直接所有權
    • 合資企業所有權

12. 依最終用途分類的醫藥物流倉儲市場

  • 動物用藥品
  • 人類藥物
    • 非處方藥
    • 處方藥

第13章：各地區醫藥物流倉儲市場

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第14章：依組別分類的醫藥物流倉儲市場

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章 各國醫藥物流倉儲市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章：美國醫藥物流倉儲市場

第17章：中國醫藥流倉儲市場

第18章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • ADAllen Pharma
  • Agility Public Warehousing Company KSCP
  • Alloga Ltd.
  • AmerisourceBergen Corporation
  • Bio Pharma Logistics
  • Cardinal Health, Inc.
  • CEVA Logistics AG
  • DB Schenker GmbH
  • DHL International GmbH
  • DSV A/S
  • FedEx Corporation
  • Geodis SA
  • Kuehne+Nagel International AG
  • McKesson Corporation
  • Rhenus SE & Co. KG
  • United Parcel Service, Inc.
  • XPO Logistics, Inc.
  • Yusen Logistics Co., Ltd
Product Code: MRR-0A380695189D

The Warehousing in Pharmaceutical Logistics Market was valued at USD 9.02 billion in 2025 and is projected to grow to USD 9.69 billion in 2026, with a CAGR of 6.70%, reaching USD 14.21 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 9.02 billion
Estimated Year [2026] USD 9.69 billion
Forecast Year [2032] USD 14.21 billion
CAGR (%) 6.70%

Setting the strategic context for pharmaceutical warehousing where cold chain integrity, regulatory compliance, and network resilience converge into competitive advantage

The pharmaceutical logistics landscape increasingly hinges on the integrity of warehousing operations that preserve product quality, meet regulatory expectations, and support responsive supply chains. Rising complexity in therapy modalities, extended cold chain requirements, and intensified scrutiny from regulators have elevated warehousing from a cost center to a strategic capability. This executive summary frames warehousing not simply as storage but as a pivotal node that influences patient access, brand trust, and commercial agility.

As companies diversify manufacturing footprints and seek resilient distribution pathways, warehousing decisions must account for a range of operational, regulatory, and commercial constraints. The interplay between temperature control, specialized handling for sensitive biologics, and the need for scalable capacity creates both challenges and opportunities. In many cases, warehouse design and service mix determine the feasibility of rapid product launches, recall management, and responsiveness during demand surges. Consequently, leaders must adopt a systems view that links physical assets, service partners, and governance mechanisms to measurable business outcomes.

This section establishes the context for subsequent analysis by outlining key pressures reshaping warehousing strategy, highlighting why logistics leaders should prioritize investments that balance compliance, cost efficiency, and agility. The following content delves into transformative shifts, tariff impacts, segmentation insights, regional dynamics, competitive positioning, and pragmatic recommendations to convert insight into action.

How technology adoption, evolving outsourcing models, and sustainability requirements are reshaping pharmaceutical warehousing operations and strategic priorities

Shifts across technology, regulation, and commercial models are redefining the expectations placed on pharmaceutical warehousing. Advanced digital tools such as continuous environmental monitoring, edge analytics, and integrated warehouse management systems have moved from pilot projects to operational essentials. As a result, many operators are transitioning from manual, episodic oversight to continuous, data-driven control that reduces risk and drives process standardization. This technological transition also enables enhanced traceability and auditability, which regulators and commercial partners increasingly demand.

Concurrently, the sector is witnessing structural changes in service delivery. The line between traditional public warehousing and comprehensive logistics partnerships is blurring as contract models expand to include value-added services, serialization, and regulatory support. Outsourcing decisions are shifting toward providers that can offer multi-modal capabilities and a proven track record in handling complex therapy profiles. Meanwhile, environmental goals and energy efficiency are introducing new design criteria for facilities, especially for temperature-controlled storage where energy intensity is high.

Taken together, these trends are reorganizing how stakeholders evaluate warehousing investments. Organizations that embed digital controls, prioritize interoperability with transport and clinical systems, and select partners with strong compliance frameworks will be better positioned to manage uncertainty while enabling faster commercialization and market responsiveness.

Navigating the operational consequences of recent U.S. tariff adjustments and their influence on warehousing footprint, inventory strategies, and supply continuity

Tariff dynamics in the United States through 2025 have added a layer of complexity to pharmaceutical supply chain decision-making, influencing sourcing, routing, and warehousing strategies. While finished pharmaceuticals and many active pharmaceutical ingredients benefit from preferential treatments and harmonized regulatory protocols, ancillary equipment, packaging materials, and certain specialty components have faced variable tariff exposure. This variability has prompted companies to re-evaluate the composition of inventory held domestically versus at international distribution hubs.

In response, several manufacturers and distributors have adopted dual-location strategies to mitigate cost volatility, placing non-critical stock in regional bonded or nearshore facilities while maintaining rigorous temperature-controlled capacity for sensitive products closer to demand centers. These adjustments seek to balance landed cost implications with service-level commitments and regulatory constraints. Additionally, tariff-driven shifts have accelerated conversations about nearshoring and vertical integration for critical inputs, which in turn affect warehousing footprint and throughput patterns.

Operationally, warehousing teams have had to enhance procurement coordination, increase invoice and duty visibility, and collaborate more closely with customs brokers to optimize flows. As trade policies continue to evolve, warehousing flexibility, inventory segmentation, and contractual agility with third-party providers remain essential levers to preserve continuity of supply and control total landed costs without compromising product integrity.

A multi-dimensional segmentation framework clarifying temperature, service, storage, end-use, and ownership lenses to align warehousing capabilities with product and commercial risk

Segmentation provides a practical lens to align warehousing capabilities with product risk profiles and commercial needs. Based on Temperature Control, market is studied across Ambient Storage and Temperature Controlled Storage. The Temperature Controlled Storage is further studied across Chilled Storage and Frozen Storage. This temperature-based framing clarifies the capital and compliance differentials between ambient distribution and specialized cold chain operations, and it underscores why facility infrastructure, energy management, and validation protocols vary significantly by segment.

Based on Service Type, market is studied across Contract Warehousing, Dedicated Warehousing, and Public Warehousing. The Contract Warehousing is further studied across Third Party Logistics and Value Added Services. The Third Party Logistics is further studied across 3PL and 4PL. This service-oriented segmentation highlights distinct contractual relationships and performance expectations, where dedicated models emphasize control and customization, contract arrangements offer integrated service bundles, and public warehousing supports flexibility for variable demand. The further distinctions among 3PL and 4PL roles illuminate differences in orchestration responsibilities and strategic oversight.

Based on Storage Type, market is studied across Bulk Storage, Palletized Storage, and Rack Storage. Storage configuration affects throughput, picking accuracy, and the economics of space utilization, with implications for automation opportunities and handling processes. Based on End Use, market is studied across Animal Pharmaceuticals and Human Pharmaceuticals. The Human Pharmaceuticals is further studied across Over The Counter and Prescription Drugs. End-use segmentation determines regulatory touchpoints, labeling complexity, and required traceability. Finally, based on Ownership Type, market is studied across Leased Property and Owned Property. The Leased Property is further studied across Long Term Lease and Short Term Lease. The Owned Property is further studied across Direct Owned and Joint Venture Owned. Ownership considerations shape capital allocation, responsiveness to demand fluctuations, and long-term strategic flexibility. Altogether, these segmentation lenses guide decisions about facility design, partner selection, and investment prioritization.

Regional warehousing dynamics and distribution priorities across established and emerging markets shaping facility design, compliance strategy, and distribution networks

Regional dynamics materially influence warehousing requirements and strategic priorities across major global markets. In the Americas, demand centers and regulatory expectations drive investments in geographically distributed temperature-controlled nodes and robust cold chain corridors that support fast replenishment and strong visibility. The region's emphasis on patient access and commercial launch speed places a premium on near-patient distribution options and high-reliability third-party partnerships.

In Europe, Middle East & Africa, heterogenous regulatory environments and diverse climatic conditions necessitate adaptable facility designs and region-specific compliance strategies. Cross-border movements within Europe demand harmonized labeling and serialization practices, while markets in the Middle East & Africa often require tailored logistics solutions that account for infrastructure variability and differing import regimes. These dynamics favor partners with regional expertise and the ability to provide compliant value-added services across multiple jurisdictions.

In the Asia-Pacific region, rapid biopharma manufacturing growth and expanding domestic demand are driving substantial capacity additions and an increased focus on cold chain modernization. The region's complex trade lanes and the prevalence of both large urban centers and remote distribution points underscore the need for modular warehousing solutions that balance centralized hubs with last-mile capabilities. Collectively, regional insights indicate that a one-size-fits-all warehousing strategy is insufficient; instead, firms should pursue geographically tailored approaches that respect local regulatory regimes, infrastructure realities, and commercial timelines.

How provider capabilities, integrated service portfolios, and digital transparency are redefining competitive differentiation in pharmaceutical warehousing and logistics

Competitive positioning among warehousing providers is increasingly differentiated by capability depth, regulatory track record, and integration with broader supply chain services. Leading firms emphasize validated cold chain infrastructure, strong quality management systems, and the ability to deliver end-to-end documentation that supports regulatory inspections and audits. These capabilities are often augmented by investment in digital platforms that enable real-time temperature monitoring, automated deviation alerts, and seamless data handoffs with customers' enterprise systems.

Service portfolios that bundle storage with serialization, relabeling, clinical trial support, and reverse logistics are gaining traction because they reduce handoffs and compress lead times. Providers that demonstrate transparent performance metrics, scalable capacity, and a history of managing high-value biologics command stronger commercial trust. At the same time, new entrants leveraging modular warehouses and cloud-native warehouse management systems are challenging incumbent models by offering rapid deployment and lower fixed-cost structures for emerging product lines.

Partnership criteria have therefore expanded beyond price and location; companies increasingly assess prospective providers on validation velocity, sustainability commitments, disaster recovery planning, and data interoperability. As a result, long-term relationships are now rooted in measurable KPIs, collaborative governance, and the ability to co-develop processes that mitigate product and patient risk.

Actionable steps for logistics and supply chain executives to strengthen cold chain integrity, contractual agility, and sustainable resilient warehousing operations

Industry leaders should prioritize investments that simultaneously reduce operational risk and enable faster time-to-market for new therapies. First, strengthen digital controls by deploying continuous environmental monitoring integrated with alerting and automated corrective workflows to reduce human latency in deviation response. This will improve compliance and lower the operational burden during inspections and adverse-event investigations. Second, align outsourcing strategies to the clinical and commercial lifecycle by using dedicated facilities for high-value or sensitive products and flexible contract or public options for lower-risk inventories. This mix permits capital efficiency while preserving service levels.

Third, build tariff and trade agility into procurement and inventory policies by maintaining segmented inventory pools that can be routed through bonded or nearshore facilities when supply chain cost pressures shift. Fourth, prioritize partnerships with providers offering validated cold chain credentials and value-added services such as serialization, kitting, and returns handling to reduce complexity across life-cycle transitions. Fifth, embed sustainability and energy-efficiency targets into facility selection and retrofit decisions, particularly for temperature-controlled operations where energy use is significant. Finally, establish clear governance with measurable KPIs for partner performance, and run periodic tabletop exercises to stress-test continuity plans and regulatory readiness. Together, these actions provide a pragmatic road map to fortify warehousing as a strategic enabler rather than a reactive constraint.

Transparent mixed-method research approach combining expert interviews, facility observations, segmentation mapping, and scenario analysis to validate warehousing insights

This research adopted a multi-method approach to ensure comprehensiveness and verifiability. Primary qualitative inputs were gathered through structured interviews with senior supply chain, quality, and regulatory leaders across manufacturers, distributors, and warehousing providers, supplemented by site visits to temperature-controlled facilities to observe validation and monitoring practices. These firsthand observations were triangulated with secondary sources including regulatory guidance, industry white papers, and recent academic literature on cold chain logistics and temperature-sensitive product management.

Analytical methods included capability mapping, gap analysis, and scenario planning to explore the implications of tariff shifts and regional distribution strategies. The segmentation framework was constructed by synthesizing operational criteria, service models, storage configurations, end-use distinctions, and ownership structures to create actionable decision lenses for executives. Quality assurance measures included cross-validation of emerging themes across multiple expert interviews and the review of compliance documentation to verify assertions regarding standard operating practices and technological adoption. Where possible, evidence-based examples and case observations were used to illustrate practical outcomes and lessons learned.

Final synthesis emphasizing warehousing as a strategic capability linking product integrity, regulatory readiness, and commercial responsiveness in life sciences

Robust warehousing strategy is an essential determinant of supply chain resilience and commercial agility for pharmaceutical companies. The interplay between temperature control requirements, service models, storage configurations, and ownership choices creates a complex decision space that must be navigated with clear priorities and operational rigor. Organizations that invest in validated cold chain infrastructure, digital monitoring, and partnerships with capable providers will reduce product risk and improve readiness for regulatory scrutiny.

Moreover, the evolving trade environment underscores the importance of flexible inventory strategies and geographically informed network design. By aligning warehousing models to therapy risk profiles and commercial lifecycles, companies can optimize capital deployment while preserving speed to market. Ultimately, warehousing should be treated as a strategic lever: when designed and governed effectively, it supports patient-centric outcomes, protects brand integrity, and enables organizations to respond nimbly to both market opportunity and disruption.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Warehousing in Pharmaceutical Logistics Market, by Temperature Control

  • 8.1. Ambient Storage
  • 8.2. Temperature Controlled Storage
    • 8.2.1. Chilled Storage
    • 8.2.2. Frozen Storage

9. Warehousing in Pharmaceutical Logistics Market, by Service Type

  • 9.1. Contract Warehousing
    • 9.1.1. Third Party Logistics
      • 9.1.1.1. 3PL
      • 9.1.1.2. 4PL
    • 9.1.2. Value Added Services
  • 9.2. Dedicated Warehousing
  • 9.3. Public Warehousing

10. Warehousing in Pharmaceutical Logistics Market, by Storage Type

  • 10.1. Bulk Storage
  • 10.2. Palletized Storage
  • 10.3. Rack Storage

11. Warehousing in Pharmaceutical Logistics Market, by Ownership Type

  • 11.1. Leased Property
    • 11.1.1. Long Term Lease
    • 11.1.2. Short Term Lease
  • 11.2. Owned Property
    • 11.2.1. Direct Owned
    • 11.2.2. Joint Venture Owned

12. Warehousing in Pharmaceutical Logistics Market, by End Use

  • 12.1. Animal Pharmaceuticals
  • 12.2. Human Pharmaceuticals
    • 12.2.1. Over The Counter
    • 12.2.2. Prescription Drugs

13. Warehousing in Pharmaceutical Logistics Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Warehousing in Pharmaceutical Logistics Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Warehousing in Pharmaceutical Logistics Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Warehousing in Pharmaceutical Logistics Market

17. China Warehousing in Pharmaceutical Logistics Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. ADAllen Pharma
  • 18.6. Agility Public Warehousing Company KSCP
  • 18.7. Alloga Ltd.
  • 18.8. AmerisourceBergen Corporation
  • 18.9. Bio Pharma Logistics
  • 18.10. Cardinal Health, Inc.
  • 18.11. CEVA Logistics AG
  • 18.12. DB Schenker GmbH
  • 18.13. DHL International GmbH
  • 18.14. DSV A/S
  • 18.15. FedEx Corporation
  • 18.16. Geodis SA
  • 18.17. Kuehne + Nagel International AG
  • 18.18. McKesson Corporation
  • 18.19. Rhenus SE & Co. KG
  • 18.20. United Parcel Service, Inc.
  • 18.21. XPO Logistics, Inc.
  • 18.22. Yusen Logistics Co., Ltd

LIST OF FIGURES

  • FIGURE 1. GLOBAL WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TEMPERATURE CONTROL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY STORAGE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY OWNERSHIP TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY END USE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TEMPERATURE CONTROL, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY AMBIENT STORAGE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY AMBIENT STORAGE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY AMBIENT STORAGE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TEMPERATURE CONTROLLED STORAGE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TEMPERATURE CONTROLLED STORAGE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TEMPERATURE CONTROLLED STORAGE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TEMPERATURE CONTROLLED STORAGE, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY CHILLED STORAGE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY CHILLED STORAGE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY CHILLED STORAGE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY FROZEN STORAGE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY FROZEN STORAGE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY FROZEN STORAGE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY CONTRACT WAREHOUSING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY CONTRACT WAREHOUSING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY CONTRACT WAREHOUSING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY CONTRACT WAREHOUSING, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY THIRD PARTY LOGISTICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY THIRD PARTY LOGISTICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY THIRD PARTY LOGISTICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY THIRD PARTY LOGISTICS, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY 3PL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY 3PL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY 3PL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY 4PL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY 4PL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY 4PL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY VALUE ADDED SERVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY VALUE ADDED SERVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY VALUE ADDED SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY DEDICATED WAREHOUSING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY DEDICATED WAREHOUSING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY DEDICATED WAREHOUSING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PUBLIC WAREHOUSING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PUBLIC WAREHOUSING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PUBLIC WAREHOUSING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY STORAGE TYPE, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY BULK STORAGE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY BULK STORAGE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY BULK STORAGE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PALLETIZED STORAGE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PALLETIZED STORAGE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PALLETIZED STORAGE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY RACK STORAGE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY RACK STORAGE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY RACK STORAGE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY OWNERSHIP TYPE, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY LEASED PROPERTY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY LEASED PROPERTY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY LEASED PROPERTY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY LEASED PROPERTY, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY LONG TERM LEASE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY LONG TERM LEASE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY LONG TERM LEASE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY SHORT TERM LEASE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY SHORT TERM LEASE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY SHORT TERM LEASE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY OWNED PROPERTY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY OWNED PROPERTY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY OWNED PROPERTY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY OWNED PROPERTY, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY DIRECT OWNED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY DIRECT OWNED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY DIRECT OWNED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY JOINT VENTURE OWNED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY JOINT VENTURE OWNED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY JOINT VENTURE OWNED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY ANIMAL PHARMACEUTICALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY ANIMAL PHARMACEUTICALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY ANIMAL PHARMACEUTICALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY HUMAN PHARMACEUTICALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY HUMAN PHARMACEUTICALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY HUMAN PHARMACEUTICALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY HUMAN PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY OVER THE COUNTER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY OVER THE COUNTER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY OVER THE COUNTER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRESCRIPTION DRUGS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRESCRIPTION DRUGS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY PRESCRIPTION DRUGS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 86. AMERICAS WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 87. AMERICAS WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TEMPERATURE CONTROL, 2018-2032 (USD MILLION)
  • TABLE 88. AMERICAS WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TEMPERATURE CONTROLLED STORAGE, 2018-2032 (USD MILLION)
  • TABLE 89. AMERICAS WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 90. AMERICAS WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY CONTRACT WAREHOUSING, 2018-2032 (USD MILLION)
  • TABLE 91. AMERICAS WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY THIRD PARTY LOGISTICS, 2018-2032 (USD MILLION)
  • TABLE 92. AMERICAS WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY STORAGE TYPE, 2018-2032 (USD MILLION)
  • TABLE 93. AMERICAS WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY OWNERSHIP TYPE, 2018-2032 (USD MILLION)
  • TABLE 94. AMERICAS WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY LEASED PROPERTY, 2018-2032 (USD MILLION)
  • TABLE 95. AMERICAS WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY OWNED PROPERTY, 2018-2032 (USD MILLION)
  • TABLE 96. AMERICAS WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 97. AMERICAS WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY HUMAN PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 98. NORTH AMERICA WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 99. NORTH AMERICA WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TEMPERATURE CONTROL, 2018-2032 (USD MILLION)
  • TABLE 100. NORTH AMERICA WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TEMPERATURE CONTROLLED STORAGE, 2018-2032 (USD MILLION)
  • TABLE 101. NORTH AMERICA WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 102. NORTH AMERICA WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY CONTRACT WAREHOUSING, 2018-2032 (USD MILLION)
  • TABLE 103. NORTH AMERICA WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY THIRD PARTY LOGISTICS, 2018-2032 (USD MILLION)
  • TABLE 104. NORTH AMERICA WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY STORAGE TYPE, 2018-2032 (USD MILLION)
  • TABLE 105. NORTH AMERICA WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY OWNERSHIP TYPE, 2018-2032 (USD MILLION)
  • TABLE 106. NORTH AMERICA WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY LEASED PROPERTY, 2018-2032 (USD MILLION)
  • TABLE 107. NORTH AMERICA WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY OWNED PROPERTY, 2018-2032 (USD MILLION)
  • TABLE 108. NORTH AMERICA WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 109. NORTH AMERICA WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY HUMAN PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 110. LATIN AMERICA WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 111. LATIN AMERICA WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TEMPERATURE CONTROL, 2018-2032 (USD MILLION)
  • TABLE 112. LATIN AMERICA WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TEMPERATURE CONTROLLED STORAGE, 2018-2032 (USD MILLION)
  • TABLE 113. LATIN AMERICA WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 114. LATIN AMERICA WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY CONTRACT WAREHOUSING, 2018-2032 (USD MILLION)
  • TABLE 115. LATIN AMERICA WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY THIRD PARTY LOGISTICS, 2018-2032 (USD MILLION)
  • TABLE 116. LATIN AMERICA WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY STORAGE TYPE, 2018-2032 (USD MILLION)
  • TABLE 117. LATIN AMERICA WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY OWNERSHIP TYPE, 2018-2032 (USD MILLION)
  • TABLE 118. LATIN AMERICA WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY LEASED PROPERTY, 2018-2032 (USD MILLION)
  • TABLE 119. LATIN AMERICA WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY OWNED PROPERTY, 2018-2032 (USD MILLION)
  • TABLE 120. LATIN AMERICA WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 121. LATIN AMERICA WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY HUMAN PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 122. EUROPE, MIDDLE EAST & AFRICA WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 123. EUROPE, MIDDLE EAST & AFRICA WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TEMPERATURE CONTROL, 2018-2032 (USD MILLION)
  • TABLE 124. EUROPE, MIDDLE EAST & AFRICA WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TEMPERATURE CONTROLLED STORAGE, 2018-2032 (USD MILLION)
  • TABLE 125. EUROPE, MIDDLE EAST & AFRICA WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 126. EUROPE, MIDDLE EAST & AFRICA WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY CONTRACT WAREHOUSING, 2018-2032 (USD MILLION)
  • TABLE 127. EUROPE, MIDDLE EAST & AFRICA WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY THIRD PARTY LOGISTICS, 2018-2032 (USD MILLION)
  • TABLE 128. EUROPE, MIDDLE EAST & AFRICA WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY STORAGE TYPE, 2018-2032 (USD MILLION)
  • TABLE 129. EUROPE, MIDDLE EAST & AFRICA WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY OWNERSHIP TYPE, 2018-2032 (USD MILLION)
  • TABLE 130. EUROPE, MIDDLE EAST & AFRICA WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY LEASED PROPERTY, 2018-2032 (USD MILLION)
  • TABLE 131. EUROPE, MIDDLE EAST & AFRICA WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY OWNED PROPERTY, 2018-2032 (USD MILLION)
  • TABLE 132. EUROPE, MIDDLE EAST & AFRICA WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 133. EUROPE, MIDDLE EAST & AFRICA WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY HUMAN PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 134. EUROPE WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 135. EUROPE WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TEMPERATURE CONTROL, 2018-2032 (USD MILLION)
  • TABLE 136. EUROPE WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TEMPERATURE CONTROLLED STORAGE, 2018-2032 (USD MILLION)
  • TABLE 137. EUROPE WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 138. EUROPE WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY CONTRACT WAREHOUSING, 2018-2032 (USD MILLION)
  • TABLE 139. EUROPE WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY THIRD PARTY LOGISTICS, 2018-2032 (USD MILLION)
  • TABLE 140. EUROPE WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY STORAGE TYPE, 2018-2032 (USD MILLION)
  • TABLE 141. EUROPE WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY OWNERSHIP TYPE, 2018-2032 (USD MILLION)
  • TABLE 142. EUROPE WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY LEASED PROPERTY, 2018-2032 (USD MILLION)
  • TABLE 143. EUROPE WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY OWNED PROPERTY, 2018-2032 (USD MILLION)
  • TABLE 144. EUROPE WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 145. EUROPE WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY HUMAN PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 146. MIDDLE EAST WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 147. MIDDLE EAST WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TEMPERATURE CONTROL, 2018-2032 (USD MILLION)
  • TABLE 148. MIDDLE EAST WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TEMPERATURE CONTROLLED STORAGE, 2018-2032 (USD MILLION)
  • TABLE 149. MIDDLE EAST WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 150. MIDDLE EAST WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY CONTRACT WAREHOUSING, 2018-2032 (USD MILLION)
  • TABLE 151. MIDDLE EAST WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY THIRD PARTY LOGISTICS, 2018-2032 (USD MILLION)
  • TABLE 152. MIDDLE EAST WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY STORAGE TYPE, 2018-2032 (USD MILLION)
  • TABLE 153. MIDDLE EAST WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY OWNERSHIP TYPE, 2018-2032 (USD MILLION)
  • TABLE 154. MIDDLE EAST WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY LEASED PROPERTY, 2018-2032 (USD MILLION)
  • TABLE 155. MIDDLE EAST WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY OWNED PROPERTY, 2018-2032 (USD MILLION)
  • TABLE 156. MIDDLE EAST WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 157. MIDDLE EAST WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY HUMAN PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 158. AFRICA WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 159. AFRICA WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TEMPERATURE CONTROL, 2018-2032 (USD MILLION)
  • TABLE 160. AFRICA WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TEMPERATURE CONTROLLED STORAGE, 2018-2032 (USD MILLION)
  • TABLE 161. AFRICA WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 162. AFRICA WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY CONTRACT WAREHOUSING, 2018-2032 (USD MILLION)
  • TABLE 163. AFRICA WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY THIRD PARTY LOGISTICS, 2018-2032 (USD MILLION)
  • TABLE 164. AFRICA WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY STORAGE TYPE, 2018-2032 (USD MILLION)
  • TABLE 165. AFRICA WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY OWNERSHIP TYPE, 2018-2032 (USD MILLION)
  • TABLE 166. AFRICA WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY LEASED PROPERTY, 2018-2032 (USD MILLION)
  • TABLE 167. AFRICA WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY OWNED PROPERTY, 2018-2032 (USD MILLION)
  • TABLE 168. AFRICA WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 169. AFRICA WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY HUMAN PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 170. ASIA-PACIFIC WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 171. ASIA-PACIFIC WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TEMPERATURE CONTROL, 2018-2032 (USD MILLION)
  • TABLE 172. ASIA-PACIFIC WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TEMPERATURE CONTROLLED STORAGE, 2018-2032 (USD MILLION)
  • TABLE 173. ASIA-PACIFIC WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 174. ASIA-PACIFIC WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY CONTRACT WAREHOUSING, 2018-2032 (USD MILLION)
  • TABLE 175. ASIA-PACIFIC WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY THIRD PARTY LOGISTICS, 2018-2032 (USD MILLION)
  • TABLE 176. ASIA-PACIFIC WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY STORAGE TYPE, 2018-2032 (USD MILLION)
  • TABLE 177. ASIA-PACIFIC WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY OWNERSHIP TYPE, 2018-2032 (USD MILLION)
  • TABLE 178. ASIA-PACIFIC WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY LEASED PROPERTY, 2018-2032 (USD MILLION)
  • TABLE 179. ASIA-PACIFIC WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY OWNED PROPERTY, 2018-2032 (USD MILLION)
  • TABLE 180. ASIA-PACIFIC WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 181. ASIA-PACIFIC WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY HUMAN PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 182. GLOBAL WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 183. ASEAN WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 184. ASEAN WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TEMPERATURE CONTROL, 2018-2032 (USD MILLION)
  • TABLE 185. ASEAN WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TEMPERATURE CONTROLLED STORAGE, 2018-2032 (USD MILLION)
  • TABLE 186. ASEAN WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 187. ASEAN WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY CONTRACT WAREHOUSING, 2018-2032 (USD MILLION)
  • TABLE 188. ASEAN WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY THIRD PARTY LOGISTICS, 2018-2032 (USD MILLION)
  • TABLE 189. ASEAN WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY STORAGE TYPE, 2018-2032 (USD MILLION)
  • TABLE 190. ASEAN WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY OWNERSHIP TYPE, 2018-2032 (USD MILLION)
  • TABLE 191. ASEAN WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY LEASED PROPERTY, 2018-2032 (USD MILLION)
  • TABLE 192. ASEAN WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY OWNED PROPERTY, 2018-2032 (USD MILLION)
  • TABLE 193. ASEAN WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 194. ASEAN WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY HUMAN PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 195. GCC WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 196. GCC WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TEMPERATURE CONTROL, 2018-2032 (USD MILLION)
  • TABLE 197. GCC WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TEMPERATURE CONTROLLED STORAGE, 2018-2032 (USD MILLION)
  • TABLE 198. GCC WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 199. GCC WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY CONTRACT WAREHOUSING, 2018-2032 (USD MILLION)
  • TABLE 200. GCC WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY THIRD PARTY LOGISTICS, 2018-2032 (USD MILLION)
  • TABLE 201. GCC WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY STORAGE TYPE, 2018-2032 (USD MILLION)
  • TABLE 202. GCC WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY OWNERSHIP TYPE, 2018-2032 (USD MILLION)
  • TABLE 203. GCC WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY LEASED PROPERTY, 2018-2032 (USD MILLION)
  • TABLE 204. GCC WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY OWNED PROPERTY, 2018-2032 (USD MILLION)
  • TABLE 205. GCC WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 206. GCC WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY HUMAN PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 207. EUROPEAN UNION WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 208. EUROPEAN UNION WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TEMPERATURE CONTROL, 2018-2032 (USD MILLION)
  • TABLE 209. EUROPEAN UNION WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TEMPERATURE CONTROLLED STORAGE, 2018-2032 (USD MILLION)
  • TABLE 210. EUROPEAN UNION WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 211. EUROPEAN UNION WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY CONTRACT WAREHOUSING, 2018-2032 (USD MILLION)
  • TABLE 212. EUROPEAN UNION WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY THIRD PARTY LOGISTICS, 2018-2032 (USD MILLION)
  • TABLE 213. EUROPEAN UNION WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY STORAGE TYPE, 2018-2032 (USD MILLION)
  • TABLE 214. EUROPEAN UNION WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY OWNERSHIP TYPE, 2018-2032 (USD MILLION)
  • TABLE 215. EUROPEAN UNION WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY LEASED PROPERTY, 2018-2032 (USD MILLION)
  • TABLE 216. EUROPEAN UNION WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY OWNED PROPERTY, 2018-2032 (USD MILLION)
  • TABLE 217. EUROPEAN UNION WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 218. EUROPEAN UNION WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY HUMAN PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 219. BRICS WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 220. BRICS WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TEMPERATURE CONTROL, 2018-2032 (USD MILLION)
  • TABLE 221. BRICS WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TEMPERATURE CONTROLLED STORAGE, 2018-2032 (USD MILLION)
  • TABLE 222. BRICS WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 223. BRICS WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY CONTRACT WAREHOUSING, 2018-2032 (USD MILLION)
  • TABLE 224. BRICS WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY THIRD PARTY LOGISTICS, 2018-2032 (USD MILLION)
  • TABLE 225. BRICS WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY STORAGE TYPE, 2018-2032 (USD MILLION)
  • TABLE 226. BRICS WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY OWNERSHIP TYPE, 2018-2032 (USD MILLION)
  • TABLE 227. BRICS WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY LEASED PROPERTY, 2018-2032 (USD MILLION)
  • TABLE 228. BRICS WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY OWNED PROPERTY, 2018-2032 (USD MILLION)
  • TABLE 229. BRICS WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 230. BRICS WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY HUMAN PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 231. G7 WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 232. G7 WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TEMPERATURE CONTROL, 2018-2032 (USD MILLION)
  • TABLE 233. G7 WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TEMPERATURE CONTROLLED STORAGE, 2018-2032 (USD MILLION)
  • TABLE 234. G7 WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 235. G7 WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY CONTRACT WAREHOUSING, 2018-2032 (USD MILLION)
  • TABLE 236. G7 WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY THIRD PARTY LOGISTICS, 2018-2032 (USD MILLION)
  • TABLE 237. G7 WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY STORAGE TYPE, 2018-2032 (USD MILLION)
  • TABLE 238. G7 WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY OWNERSHIP TYPE, 2018-2032 (USD MILLION)
  • TABLE 239. G7 WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY LEASED PROPERTY, 2018-2032 (USD MILLION)
  • TABLE 240. G7 WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY OWNED PROPERTY, 2018-2032 (USD MILLION)
  • TABLE 241. G7 WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 242. G7 WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY HUMAN PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 243. NATO WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 244. NATO WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TEMPERATURE CONTROL, 2018-2032 (USD MILLION)
  • TABLE 245. NATO WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TEMPERATURE CONTROLLED STORAGE, 2018-2032 (USD MILLION)
  • TABLE 246. NATO WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 247. NATO WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY CONTRACT WAREHOUSING, 2018-2032 (USD MILLION)
  • TABLE 248. NATO WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY THIRD PARTY LOGISTICS, 2018-2032 (USD MILLION)
  • TABLE 249. NATO WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY STORAGE TYPE, 2018-2032 (USD MILLION)
  • TABLE 250. NATO WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY OWNERSHIP TYPE, 2018-2032 (USD MILLION)
  • TABLE 251. NATO WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY LEASED PROPERTY, 2018-2032 (USD MILLION)
  • TABLE 252. NATO WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY OWNED PROPERTY, 2018-2032 (USD MILLION)
  • TABLE 253. NATO WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 254. NATO WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY HUMAN PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 255. GLOBAL WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 256. UNITED STATES WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 257. UNITED STATES WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TEMPERATURE CONTROL, 2018-2032 (USD MILLION)
  • TABLE 258. UNITED STATES WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TEMPERATURE CONTROLLED STORAGE, 2018-2032 (USD MILLION)
  • TABLE 259. UNITED STATES WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 260. UNITED STATES WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY CONTRACT WAREHOUSING, 2018-2032 (USD MILLION)
  • TABLE 261. UNITED STATES WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY THIRD PARTY LOGISTICS, 2018-2032 (USD MILLION)
  • TABLE 262. UNITED STATES WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY STORAGE TYPE, 2018-2032 (USD MILLION)
  • TABLE 263. UNITED STATES WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY OWNERSHIP TYPE, 2018-2032 (USD MILLION)
  • TABLE 264. UNITED STATES WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY LEASED PROPERTY, 2018-2032 (USD MILLION)
  • TABLE 265. UNITED STATES WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY OWNED PROPERTY, 2018-2032 (USD MILLION)
  • TABLE 266. UNITED STATES WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 267. UNITED STATES WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY HUMAN PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 268. CHINA WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 269. CHINA WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TEMPERATURE CONTROL, 2018-2032 (USD MILLION)
  • TABLE 270. CHINA WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY TEMPERATURE CONTROLLED STORAGE, 2018-2032 (USD MILLION)
  • TABLE 271. CHINA WAREHOUSING IN PHARMACEUTICAL LOGISTICS MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 272. CHINA WAREHOUSING IN PHARMACEUTICAL LOGIST